You searched for "hearable"
MED-EL revolutionises cochlear implantation with unparalleled synchrotron dataset of temporal bones
MED-EL, a leading innovator in the field of cochlear implant research and development, has announced an agreement with the Western University (London, Canada) and Mitacs to gain exclusive access to an extraordinary synchrotron dataset of temporal bones.Jan Plzák takes helm as president of the CEORL-HNS
The Confederation of European Otorhinolaryngology Head and Neck Surgery (CEORL-HNS) proudly announces the appointment of Professor Jan Plzák as its new president.The preventative audiologist
Rob Shepheard has been championing the role of ‘the preventative audiologist’ for many years. In this article, he explores how that can be achieved.Communicating with patients in ‘Plain English’
Physicians have long been accused of using unnecessarily complicated language and impenetrable jargon as a way of maintaining their status, prestige and high earnings-potential, bamboozling the public and excluding them from meaningful discussion as part of what George Bernard Shaw...Digital otoscopy with AI diagnostic support: making diagnosis of ear disease more accessible
Following Carolina Leal’s interview with Prof De Wet Swanepoel on the HearScope system, Spotlight on Innovation asked Dr Jenny Nesgaard Pedersen to review the new AI feature in HearScope system’s capabilities. In the last decade, artificial intelligence (AI) and machine...ENT in this issue...Global Ear and Hearing
GUEST SECTION EDITORS Prof Mahmood F Bhutta, DPhil FRCS (ORL-HNS), Consultant and Honorary Professor in ENT Surgery, University Hospitals Sussex and Brighton & Sussex Medical School, UK. E: m.bhutta@doctors.org.uk Prof Jackie L Clark, MS, PhD, Clinical Professor, Behavioral & Brain...OBITUARY: Max McCormick
It is with great sadness that we record the passing of Max McCormick, a treasured friend and an eminent and greatly valued colleague. Max was a larger-than-life charismatic character who was both loved and esteemed by the entire UK ENT...The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials
One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...
CRSwNP, another monoclonal antibody
Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...
